Home Newsfeeds Credit Suisse Maintains Neutral on U.S. Bancorp, Lowers Price Target to $54

Credit Suisse Maintains Neutral on U.S. Bancorp, Lowers Price Target to $54

Credit Suisse analyst Susan Roth Katzke maintains U.S. Bancorp (NYSE:USB) with a Neutral and lowers the price target from $57 to $54.

byBenzinga Newsdesk

July 19, 2022

1 minute read

Credit Suisse analyst Susan Roth Katzke maintains U.S. Bancorp (NYSE:USB) with a Neutral and lowers the price target from $57 to $54.

Spot Bitcoin ETFs Are ‘Orange FOMO Poker Chips,’ Jim Bianco Warns

By Murtuza Merchant

May 20, 10:03 AM

Jim Bianco, founder of Bianco Research, has cast a critical eye on the recent popularity of spot Bitcoin ETFs, painting a picture of these instruments as potentially hindering, rather than helping, the growth of a decent

BTC

Analyst Says Alnylam’s New Patisiran Data Shows Disease Slowing With Early Intervention, But Survival Benefit Remains Of Interest

By Vandana Singh

May 22, 5:33 PM

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) released new results from an interim analysis of exploratory data from the open-label extension (OLE) period of the APOLLO-B Phase 3 study of patisiran, for the treatment of transthyretin-mediated (ATTR)

ALNY

Analyst Ratings

Analyst Ratings for Generac Hldgs

By Benzinga Insights

October 14, 11:51 AM

Over the past 3 months, 10 analysts have published their opinion on Generac Hldgs (NYSE:GNRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

GNRC